Press releases

All press releases Regulatory

Regulatory press release 2022-02-18

Xspray Pharma publishes Q4 Year-End report 2021

Regulatory press release 2022-02-07

Xspray Pharma appoints Global Head of Marketing and Sales

Regulatory press release 2022-01-13

FDA allows review of application for market approval for Xspray Pharma’s Dasynoc™

Regulatory press release 2021-11-30

Number of shares and votes in Xspray Pharma

Press release 2021-11-18

Xspray Pharma submits application for market approval to FDA for its product candidate Dasynoc

Press release 2021-11-15

Xspray Pharma strengthens the organization with IR and Communications function

Regulatory press release 2021-11-08

Xspray Pharma completes a directed new share issue to Flerie Invest, raising approximately SEK 100 million

Regulatory press release 2021-10-26

Xspray Pharma publishes interim report Q3, January – September 2021

Regulatory press release 2021-10-25

Xspray Pharma brings forward publication of the Q3 interim report

Regulatory press release 2021-10-15

Xspray Pharma’s Nomination Committee for the Annual General Meeting 2022

Subscribe